Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary

Publisher: Karger

E-ISSN: 1662-6575|7|2|503-508

ISSN: 1662-6575

Source: Case Reports in Oncology, Vol.7, Iss.2, 2014-07, pp. : 503-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract